| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 1016 | 2018 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 653 | 2017 |
| Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ... The Lancet 391 (10135), 2107-2115, 2018 | 470 | 2018 |
| A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study T Duman, D Uluduz, I Midi, H Bektas, Y Kablan, BK Goksel, A Milanlioglu, ... Journal of Stroke and Cerebrovascular Diseases 26 (8), 1848-1857, 2017 | 245 | 2017 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 192 | 2018 |
| Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large-or small-vessel disease: the … RA Bernstein, H Kamel, CB Granger, JP Piccini, PP Sethi, JM Katz, ... Jama 325 (21), 2169-2177, 2021 | 155 | 2021 |
| Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial RG Hart, M Sharma, H Mundl, A Shoamanesh, SE Kasner, SD Berkowitz, ... European stroke journal 1 (3), 146-154, 2016 | 111 | 2016 |
| Aortic arch atherosclerosis in patients with embolic stroke of undetermined source: an exploratory analysis of the NAVIGATE ESUS trial G Ntaios, LA Pearce, E Meseguer, M Endres, P Amarenco, S Ozturk, ... Stroke 50 (11), 3184-3190, 2019 | 87 | 2019 |
| Elevated levels of RDW is associated with non-valvular atrial fibrillation B Güngör, KS Özcan, I Erdinler, A Ekmekçi, AT Alper, D Osmonov, N Çalık, ... Journal of thrombosis and thrombolysis 37, 404-410, 2014 | 85 | 2014 |
| Noncontrast computed tomography signs as predictors of hematoma expansion, clinical outcome, and response to tranexamic acid in acute intracerebral hemorrhage ZK Law, A Ali, K Krishnan, A Bischoff, JP Appleton, P Scutt, L Woodhouse, ... Stroke 51 (1), 121-128, 2020 | 70 | 2020 |
| Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention KS Özcan, D Osmonov, E Toprak, B Güngör, A Tatlısu, A Ekmekçi, A Kaya, ... Cardiology journal 21 (3), 238-244, 2014 | 61 | 2014 |
| Cardiac device-related endocarditis: 31-Years’ experience D Osmonov, KS Ozcan, I Erdinler, S Altay, E Yildirim, C Turkkan, ... Journal of cardiology 61 (2), 175-180, 2013 | 58 | 2013 |
| Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial N Sprigg, K Robson, P Bath, R Dineen, I Roberts, T Robinson, C Roffe, ... International journal of stroke 11 (6), 683-694, 2016 | 55 | 2016 |
| Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children A Ağbaş, N Canpolat, S Çalışkan, A Yılmaz, H Ekmekçi, M Mayes, ... PloS one 13 (6), e0198320, 2018 | 54 | 2018 |
| Characterization of patients with embolic strokes of undetermined source in the NAVIGATE ESUS randomized trial SE Kasner, P Lavados, M Sharma, Y Wang, Y Wang, A Dávalos, ... Journal of Stroke and Cerebrovascular Diseases 27 (6), 1673-1682, 2018 | 54 | 2018 |
| Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism A Ekmekci, N Abaci, NC Ozbey, A Agayev, N Aksakal, H Oflaz, ... Journal of endocrinological investigation 32, 611-616, 2009 | 48 | 2009 |
| Can the T-peak to T-end interval be a predictor of mortality in patients with ST-elevation myocardial infarction? MA Tatlisu, KS Özcan, B Güngör, A Ekmekçi, EI Çekirdekçi, E Arugarslan, ... Coronary artery disease 25 (5), 399-404, 2014 | 47 | 2014 |
| Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study D Uluduz, I Midi, T Duman, S Colakoglu, A Tüfekci, M Bakar, B Nazliel, ... Rheumatology 58 (4), 600-608, 2019 | 44 | 2019 |
| Assessment of Interleukin‐1 Gene Cluster Polymorphisms in Lone Atrial Fibrillation: New Insight into the Role of Inflammation in Atrial Fibrillation B Gungor, A Ekmekci, A Arman, KS Ozcan, E Ucer, AT Alper, N Calik, ... Pacing and Clinical Electrophysiology 36 (10), 1220-1227, 2013 | 44 | 2013 |
| Infections up to 76 days after stroke increase disability and death AE Learoyd, L Woodhouse, L Shaw, N Sprigg, D Bereczki, E Berge, ... Translational stroke research 8, 541-548, 2017 | 43 | 2017 |
